43 results
8-K
EX-99.1
MNKD
Mannkind Corp
8 May 24
Results of Operations and Financial Condition
4:05pm
this innovative product to patients more quickly.”
Revenue Highlights
Three Months
Ended March 31,
$ Change
% Change
(Dollars in thousands)
Royalties … for 14 days.
About MannKind
MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative inhaled therapeutic
8-K
EX-99.1
p4w0nes1 20hfd29slhi
8 Nov 22
Mannkind Corporation Reports 2022 Third Quarter Financial Results
8:04am
8-K
EX-99.1
l7vr gx4agjjew46wzqw
9 Aug 22
Mannkind Corporation Reports 2022 Second Quarter Financial Results
12:00am
8-K
EX-99.1
zmknd3k
25 May 22
Other Events
4:06pm
424B5
fts3yv3l p83uo8e
7 May 19
Prospectus supplement for primary offering
8:31am
424B5
l7p1m42z1d6shas5l
21 Dec 18
Prospectus supplement for primary offering
12:00am